Confluent, Inc. filings document the company's transition from a Nasdaq-listed public company with Class A common stock under CFLT to a private company following its completed merger with International Business Machines Corporation. The formal record includes Form 8-K material-event reports on the merger closing, shareholder voting matters, governance changes and operating results, along with Form 25 delisting and Form 15 termination of Exchange Act registration and reporting duties.
Earlier disclosure categories for Confluent addressed material agreements, capital-structure matters, officer governance events and financial results associated with its data streaming software business.
Form 144 filing for Confluent, Inc. (CFLT) reports a proposed sale of 953 common shares through Morgan Stanley Smith Barney with an aggregate market value of $17,964.05 and an approximate sale date of 08/28/2025. The filer acquired these shares on 09/26/2014 as an in-kind distribution post-IPO and lists total outstanding shares of 291,931,187.
The filing also discloses recent 10b5-1 sales on 06/05/2025: THE VISHRIA REVOCABLE TRUST sold 15,000 shares for $375,000 and THE KHAKAL TRUST sold 476 shares for $11,900. The signer certifies no undisclosed material adverse information and references reliance on trading-plan provisions where applicable.
Confluent, Inc. (CFLT) Form 144 notice: The filer proposes to sell 30,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $565,500, and an approximate sale date of 08/28/2025 on NASDAQ. The filing reports 291,931,187 shares outstanding. The shares were acquired as an in-kind distribution post IPO on 09/16/2014. The filing also discloses recent 10b5-1 sales in the past three months: 15,000 shares for $375,000 and 476 shares for $11,900 on 06/05/2025. The signer represents no knowledge of undisclosed material adverse information and, if applicable, cites reliance on a Rule 10b5-1 plan.
Confluent, Inc. (CFLT) Form 4: The reporting person, Chief Accounting Officer Phan Kong, sold 2,664 shares of Class A common stock on 08/20/2025 to cover tax obligations from RSU vesting. Sale prices ranged from $17.01 to $17.08, and the reporting person owned 237,078 shares following the transaction. The Form 4 was signed by an attorney-in-fact on 08/22/2025.
Confluent insider sale to cover taxes on vested RSUs. Sivaram Rohan, the company's Chief Financial Officer, reported a sale of 26,097 shares of Class A common stock on 08/20/2025 at prices ranging from $17.01 to $17.08 to satisfy tax obligations arising from the vesting of previously granted restricted stock units. After the transaction, the reporting person beneficially owned 636,596 shares. The Form 4 was filed as a single reporting person filing and was signed by an attorney-in-fact.
Mac Ban Ryan Norris, Chief Revenue Officer of Confluent, Inc. (CFLT), reported a sale of shares on August 20, 2025. The Form 4 shows 15,200 shares of Class A Common Stock were sold at prices ranging from $17.01 to $17.07 to cover the tax obligation arising from the vesting of previously reported restricted stock units. After the sale, the reporting person beneficially owned 397,345 shares, which includes 715 shares purchased through the companys Employee Stock Purchase Plan on August 15, 2025. The filing was signed by an attorney-in-fact on August 22, 2025.
Confluent, Inc. (CFLT) Form 4: The reporting person, Edward Jay Kreps, who is listed as both a director and the Chief Executive Officer, reported the sale of 37,707 shares of Class A common stock on 08/20/2025 under a Rule 10b5-1 trading plan adopted August 15, 2024. The shares were sold at prices ranging from $16.76 to $17.27. After the reported sale, the filing shows 377,074 shares of Class A common stock beneficially owned by the reporting person. The Form 4 was signed by an attorney-in-fact on 08/22/2025. The filer states they will provide details on the number of shares sold at each price in the stated range upon request.
Edward Jay Kreps, who serves as Chief Executive Officer and a director of Confluent, Inc. (CFLT), reported an amendment to his Form 4 disclosing a sale of 37,707 shares of Class A common stock executed under a 10b5-1 trading plan adopted August 15, 2024. The shares were sold at prices ranging from $21.63 to $22.00, with a weighted reference price reported on the form as $21.84.
Following the reported disposition, Mr. Kreps beneficially owned 414,781 shares of Class A common stock. The amended filing restates and replaces the earlier Form 4 previously submitted by the reporting person.
Confluent, Inc. (CFLT) insider transaction: Edward J. Kreps, Confluent's chief executive officer and a director, executed a series of transactions on 08/14/2025 under a 10b5-1 trading plan. He acquired 232,500 shares of Class B common stock convertible into Class A, and simultaneously sold a total of 232,500 Class A shares in two blocks—183,227 shares at prices ranging from $16.67 to $17.665 and 49,273 shares at prices ranging from $17.67 to $17.92. Following these transactions, the reporting person directly owned 452,488 shares of Class A common stock.
The filing also discloses substantial indirect holdings through trusts and derivative positions: 14,909,793 Class A shares underlying Class B shares are reported as beneficially owned following the conversion mechanics, and multiple trusts hold additional indirect interests totaling at least 2,149,984 Class A-equivalent shares. The sales were executed pursuant to a 10b5-1 plan adopted on August 15, 2024.
Altimeter Capital entities and Brad Gerstner report beneficial ownership in Confluent, Inc. Class A common stock. Each of Altimeter Capital Management General Partner LLC, Altimeter Capital Management, LP and Brad Gerstner beneficially own 13,122,150 shares, representing approximately 4.5% of Class A common stock based on 291,931,187 shares outstanding. The filing shows no sole voting or dispositive power and reports shared voting and dispositive power over these shares.
The filing also discloses that the Altimeter Entities beneficially owned 15,552,976 shares (about 5.3%) as of June 30, 2025 and 13,626,464 shares (about 5.5%) as of September 30, 2024, reflecting changes in reported holdings across periods. The Schedule 13G/A includes a certification that the position is not held to influence control of the issuer.